Immunovant Sciences Gmbh
Clinical trials sponsored by Immunovant Sciences Gmbh, explained in plain language.
-
New drug tested for Hard-to-Treat thyroid condition
Disease control CompletedThis study tested whether a drug called batoclimab could help control overactive thyroid symptoms in adults with Graves' disease. It involved 35 participants whose standard medications weren't working well enough. Researchers gave participants batoclimab for 24 weeks to see if it…
Phase: PHASE2 • Sponsor: Immunovant Sciences GmbH • Aim: Disease control
Last updated Apr 04, 2026 05:05 UTC
-
New injection shows promise for reducing bulging eyes in thyroid condition
Disease control CompletedThis completed Phase 3 trial tested whether weekly injections of an experimental drug called batoclimab could reduce eye bulging (proptosis) and inflammation in people with active Thyroid Eye Disease. The study involved 114 adults who received either the drug or a placebo for 24 …
Phase: PHASE3 • Sponsor: Immunovant Sciences GmbH • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC